Nucleate Switzerland will host a dedicated pitch session featuring selected Activator teams, showcasing some of the most promising early-stage, science-driven startups emerging from academia. These teams will present their innovations to an international audience of investors, pharma leaders, and biotech experts, creating exciting opportunities for connection, collaboration, and future growth.
Nucleate brings a highly curated pipeline of science-driven startups alongside a globally recognized network. As a global nonprofit with centralized leadership and active chapters across Europe and the US, we connect emerging innovators with investors, industry leaders, and partners worldwide.
Monday, May 4, 16:45 - 17:30, room Singapore
| Name | Position | Institution |
|---|---|---|
| Ebru Topcu Barileva | Co-Managing Director | Nucleate Switzerland |
| Company name | Pitcher | Title of presentation | Link to company website |
|---|---|---|---|
| MutaDent | Argyro Lamprou - tbc | MutaDent, the next evolution in regenerative tooth repair | https://www.innovation.uzh.ch/en/stories/fellows/isaac-bugueno-valdebenito.html |
| Talixeon Therapeutics | Paula Nunes-Hasler | Talixeon Therapeutics: Accelerating Next-Generation T Cell Therapies | https://www.linkedin.com/in/paula-nunes-hasler-271878bb/ |
| Versarys Bioscience | Lukas Schwyter | Enabling Next-Generation Interaction Studies for Microbiome, Drug Discovery, and ADME | http://www.versarys.ch/ |
| ZuriEV | Yanan Zhang | Blood-based test enabling non-invasive brain cancer diagnosis and monitoring | https://www.linkedin.com/in/yanan-zhang-neurooncology/ |
Nucleate Switzerland is part of Nucleate, a 501(c)(3) nonprofit empowering the next generation of biotech leaders. With 41 global chapters and 280+ academic institutions, Nucleate builds strong innovation communities. In Switzerland, the flagship Activator program supports academic founders in translating research into biotech ventures, fully equity-free. Through tailor-made mentorship, education, and deep integration into the Swiss life sciences ecosystem, Nucleate lowers barriers and enables founders to build impactful technologies.
